Psyence Short Term Debt vs Common Stock Analysis

PBMWW Stock

0.01 0.0003 3.41%

Psyence Biomedical financial indicator trend analysis is much more than just breaking down Psyence Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Psyence Biomedical is a good investment. Please check the relationship between Psyence Biomedical Short Term Debt and its Common Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Short Term Debt vs Common Stock

Short Term Debt vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Psyence Biomedical Short Term Debt account and Common Stock. At this time, the significance of the direction appears to have totally related.

The correlation between Psyence Biomedical's Short Term Debt and Common Stock is 1.0. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Common Stock in the same time period over historical financial statements of Psyence Biomedical Ltd, assuming nothing else is changed. The correlation between historical values of Psyence Biomedical's Short Term Debt and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Psyence Biomedical Ltd are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Short Term Debt i.e., Psyence Biomedical's Short Term Debt and Common Stock go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Short Term Debt

Common Stock

Most indicators from Psyence Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Psyence Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Selling General Administrative is likely to climb to about 1.8 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (0.20).

Psyence Biomedical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Retained Earnings	Capital Stock	Short Long Term Debt Total	Current Deferred Revenue	Inventory	Short Long Term Debt	Short Term Debt	Common Stock
Total Assets		-0.7	-0.72	0.84	-0.82	-0.73	0.99	0.99	0.77	-0.59	-0.76	0.98	-0.72	0.98	1.0	0.84	0.68	-0.67	0.6	0.6	0.6	0.6	0.6	0.6
Other Current Liab	-0.7		1.0	-0.97	0.98	0.41	-0.77	-0.77	-0.69	0.93	0.99	-0.76	1.0	-0.78	-0.7	-0.97	-1.0	0.95	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Total Current Liabilities	-0.72	1.0		-0.98	0.99	0.45	-0.79	-0.79	-0.68	0.93	0.99	-0.78	1.0	-0.8	-0.72	-0.98	-0.99	0.95	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Total Stockholder Equity	0.84	-0.97	-0.98		-1.0	-0.55	0.89	0.89	0.75	-0.88	-0.99	0.88	-0.98	0.9	0.84	1.0	0.96	-0.93	0.9	0.9	0.9	0.9	0.9	0.9
Net Debt	-0.82	0.98	0.99	-1.0		0.5	-0.87	-0.87	-0.76	0.91	0.99	-0.86	0.99	-0.87	-0.82	-1.0	-0.97	0.93	-0.92	-0.92	-0.92	-0.92	-0.92	-0.92
Accounts Payable	-0.73	0.41	0.45	-0.55	0.5		-0.73	-0.73	-0.13	0.34	0.54	-0.8	0.45	-0.79	-0.73	-0.55	-0.36	0.34	-0.34	-0.34	-0.34	-0.34	-0.34	-0.34
Cash	0.99	-0.77	-0.79	0.89	-0.87	-0.73		1.0	0.77	-0.69	-0.82	0.99	-0.79	0.99	0.99	0.89	0.74	-0.71	0.7	0.7	0.7	0.7	0.7	0.7
Cash And Short Term Investments	0.99	-0.77	-0.79	0.89	-0.87	-0.73	1.0		0.77	-0.69	-0.82	0.99	-0.79	0.99	0.99	0.89	0.74	-0.71	0.7	0.7	0.7	0.7	0.7	0.7
Net Receivables	0.77	-0.69	-0.68	0.75	-0.76	-0.13	0.77	0.77		-0.58	-0.65	0.69	-0.68	0.7	0.77	0.75	0.71	-0.72	0.6	0.6	0.6	0.6	0.6	0.6
Common Stock Shares Outstanding	-0.59	0.93	0.93	-0.88	0.91	0.34	-0.69	-0.69	-0.58		0.91	-0.67	0.93	-0.69	-0.59	-0.88	-0.91	0.78	-1.0	-1.0	-1.0	-1.0	-1.0	-1.0
Other Current Assets	-0.76	0.99	0.99	-0.99	0.99	0.54	-0.82	-0.82	-0.65	0.91		-0.82	0.99	-0.84	-0.76	-0.99	-0.98	0.93	-0.93	-0.93	-0.93	-0.93	-0.93	-0.93
Other Stockholder Equity	0.98	-0.76	-0.78	0.88	-0.86	-0.8	0.99	0.99	0.69	-0.67	-0.82		-0.78	1.0	0.98	0.88	0.73	-0.7	0.68	0.68	0.68	0.68	0.68	0.68
Total Liab	-0.72	1.0	1.0	-0.98	0.99	0.45	-0.79	-0.79	-0.68	0.93	0.99	-0.78		-0.8	-0.72	-0.98	-0.99	0.95	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Net Invested Capital	0.98	-0.78	-0.8	0.9	-0.87	-0.79	0.99	0.99	0.7	-0.69	-0.84	1.0	-0.8		0.98	0.9	0.75	-0.72	0.71	0.71	0.71	0.71	0.71	0.71
Total Current Assets	1.0	-0.7	-0.72	0.84	-0.82	-0.73	0.99	0.99	0.77	-0.59	-0.76	0.98	-0.72	0.98		0.84	0.68	-0.67	0.6	0.6	0.6	0.6	0.6	0.6
Net Working Capital	0.84	-0.97	-0.98	1.0	-1.0	-0.55	0.89	0.89	0.75	-0.88	-0.99	0.88	-0.98	0.9	0.84		0.96	-0.93	0.9	0.9	0.9	0.9	0.9	0.9
Retained Earnings	0.68	-1.0	-0.99	0.96	-0.97	-0.36	0.74	0.74	0.71	-0.91	-0.98	0.73	-0.99	0.75	0.68	0.96		-0.97	0.93	0.93	0.93	0.93	0.93	0.93
Capital Stock	-0.67	0.95	0.95	-0.93	0.93	0.34	-0.71	-0.71	-0.72	0.78	0.93	-0.7	0.95	-0.72	-0.67	-0.93	-0.97		-0.81	-0.81	-0.81	-0.81	-0.81	-0.81
Short Long Term Debt Total	0.6	-0.95	-0.95	0.9	-0.92	-0.34	0.7	0.7	0.6	-1.0	-0.93	0.68	-0.95	0.71	0.6	0.9	0.93	-0.81		1.0	1.0	1.0	1.0	1.0
Current Deferred Revenue	0.6	-0.95	-0.95	0.9	-0.92	-0.34	0.7	0.7	0.6	-1.0	-0.93	0.68	-0.95	0.71	0.6	0.9	0.93	-0.81	1.0		1.0	1.0	1.0	1.0
Inventory	0.6	-0.95	-0.95	0.9	-0.92	-0.34	0.7	0.7	0.6	-1.0	-0.93	0.68	-0.95	0.71	0.6	0.9	0.93	-0.81	1.0	1.0		1.0	1.0	1.0
Short Long Term Debt	0.6	-0.95	-0.95	0.9	-0.92	-0.34	0.7	0.7	0.6	-1.0	-0.93	0.68	-0.95	0.71	0.6	0.9	0.93	-0.81	1.0	1.0	1.0		1.0	1.0
Short Term Debt	0.6	-0.95	-0.95	0.9	-0.92	-0.34	0.7	0.7	0.6	-1.0	-0.93	0.68	-0.95	0.71	0.6	0.9	0.93	-0.81	1.0	1.0	1.0	1.0		1.0
Common Stock	0.6	-0.95	-0.95	0.9	-0.92	-0.34	0.7	0.7	0.6	-1.0	-0.93	0.68	-0.95	0.71	0.6	0.9	0.93	-0.81	1.0	1.0	1.0	1.0	1.0

Click cells to compare fundamentals

Psyence Biomedical Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Psyence Stock Analysis

When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Psyence Short Term Debt vs Common Stock Analysis

Short Term Debt vs Common Stock

Short Term Debt vs Common Stock Correlation Analysis

Correlation Coefficient

Short Term Debt

Common Stock

Psyence Biomedical fundamental ratios Correlations

Psyence Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Psyence Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Total Current Liabilities
Net Working Capital	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash

Common Stock	- 1.0	Common Stock Shares Outstanding
Short Term Debt	- 1.0	Common Stock Shares Outstanding
Short Long Term Debt	- 1.0	Common Stock Shares Outstanding
Inventory	- 1.0	Common Stock Shares Outstanding
Current Deferred Revenue	- 1.0	Common Stock Shares Outstanding
Short Long Term Debt Total	- 1.0	Common Stock Shares Outstanding